Group (n) | Placeboa (23) | WLT (39) | Tolterodine (41) | Combination (43) | P-value | ||
---|---|---|---|---|---|---|---|
Wvs T | W vs C | T vs C | |||||
OABSS | 0.22 ± 0.83 | −0.72 ± 1.71 | −1.54 ± 1.07 | −3.9 ± 1.8 | 0.022 | <0.001 | <0.001 |
Voids/24 h | - 0.21 ± 0.77 | −0.97 ± 2.3 | −2.2 ± 1.6 | −3.9 ± 2.1 | 0.034 | <0.001 | <0.001 |
VV (ml) | −4.8 ± 15.1 | 10.9 ± 24.4 | 24.6 ± 21.6 | 49.6 ± 43.9 | 0.135 | <0.001 | 0.001 |
UI/24 h | 0.02 ± 0.45 | −0.36 ± 0.58 | −0.61 ± 0.63 | −0.78 ± 0.85 | 0.113 | 0.008 | 0.281 |
RU (ml) | 0.5 ± 2.8 | −0.9 ± 3.9 | 11.5 ± 23.2 | 0.2 ± 3.8 | <0.001 | 0.109 | <0.001 |
QOL improvement in ITT patients | 11.5 % | 57.9 % | 61.5 % | 76.9 % | 0.842 | 0.059 | 0.136 |